Every SEC Form 3/4/5 on record for this filer (CIK 1038977) — 6 issuers, 69 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| FBIO | Fortress Biotech, Inc. | Executive Vice Chairman · Director | 2016-01-05 → 2026-03-20 | 12 | $1M |
| TGTX | TG THERAPEUTICS, INC. | CEO · Director | 2016-01-04 → 2026-01-09 | 19 | $82,473 |
| CKPT | Checkpoint Therapeutics, Inc. | Director | 2017-06-15 → 2025-05-30 | 10 | — |
| MBIO | MUSTANG BIO, INC. | Director · lapsed | 2020-01-17 → 2023-07-07 | 6 | — |
| ATXI | AVENUE THERAPEUTICS, INC. | Director · lapsed | 2017-08-18 → 2018-08-08 | 2 | — |
| NHLD | NATIONAL HOLDINGS CORP | Director · lapsed | 2016-09-22 → 2016-09-22 | 1 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 6 issuers are covered and open a security page; the rest are on file here only.
